iSOFT's Ideaworks Netherlands Symposium Drives Innovative Thinking

iSOFT Group LimitediSOFT Group Limited, one of the world's largest healthcare technology companies, enhanced its reputation as a global technology thought leader at its first Ideaworks for Healthcare symposium in the Netherlands, where some of the industry's leading thinkers in innovation debated the future of healthcare IT.

Ideaworks for Healthcare Netherlands, a local version of iSOFT's international Ideaworks for Healthcare concept, took place in Amsterdam on 9 February. Keynote speakers Dr Paul Gründeman, Dr Wim Huppes and Health 2.0 Ambassador Lucien Engelen discussed the necessity to innovate in medical science, healthcare politics, and the growing role of social media.

Delegates were encouraged to embrace the future through discussion and the exchange of ideas on healthcare applications that add value to healthcare. iSOFT intends to build on the generated at the event by developing prototypes that will be presented at the next Ideaworks.

"We were delighted to bring Ideaworks to the Netherlands, one of our most important markets globally," said Gary Cohen, iSOFT Group Executive Chairman & CEO. "The original concept of Ideaworks was first tested in London last year, where it was a resounding success. The Netherlands has built on the Ideaworks reputation as a truly inspiring, and a fundamental part of iSOFT’s strategy of engaging the community in the wider discussion on innovation."

Decision makers in healthcare
The day included two panel discussions on e-health and the man-machine interaction, and led by Professor Robert Stegwee of Twente University.

The Octopus
Keynote speaker Paul Gründeman, associate professor of experimental cardiothoracic and vascular surgery at UMC Utrecht, spoke of his development of the Octopus, a device that has revolutionized coronary surgery.

Dr Gründeman emphasized that innovations are not always welcomed. "Changes appear to be difficult, and medical specialists are reluctant to change," he said. "A manager that is open to changes, excellent scientists and an environment where experimental research is welcomed is crucial."

Patients at stake
Wim Huppes, philosopher and healthcare journalist, spoke of the politics that surround healthcare. "The government's prescribed DBC- and Dot-system for healthcare declarations is putting patients' wellbeing at risk," Huppes said. "A patient is unique, and so is his disease. When doctors are only allowed to declare 3,000 healthcare products and treatments, the government is limiting possible diagnoses of the patient and the resulting treatment." The policy he said is limiting a hospital's ability to focus on their core business of curing patients and is limiting innovation in healthcare.

Lucien Engelen said that patients are often ahead of the specialist when it comes to e-health. "In a growing trend, patients arrive at a doctor's office with a diagnosis of their complaints found on Google and are merely seeking confirmation." He added that people are more likely to follow advise of social networks rather than that offered by institutes and that (the lack of) trust is the key reason for this.

"Let the patient be part of the team again," Engelen said. "By respecting and addressing the information needs of the patient, the doctor-patient relation can improve significantly."

Related news articles:

About iSOFT Group
iSOFT Group Limited (ASX: ISF) is the largest health information technology company listed on the Australian Securities Exchange, and among the world's biggest providers of advanced application solutions in modern healthcare economies.

iSOFT works with healthcare professionals to design and build software applications that answer all of the difficult questions posed by today's healthcare delivery challenges. Our solutions act as a catalyst for change, supporting free exchange of critical information across diverse care settings and participating organisations.

Today, more than 13,000 provider organisations in over 40 countries use iSOFT's solutions to manage patient information and drive improvements in their core processes. The group's sustainable development is delivered through careful planning, in-depth analysis of the market, and anticipation of our clients' evolving requirements. Our business is driven by the collective talent, experience and commitment of more than 4,700 specialists in 19 countries worldwide, including more than 2,700 technology and development professionals.

A global network of iSOFT subsidiaries, supported by an extensive partner network, provides substantial experience of national healthcare markets. As a result, we offer our clients comprehensive knowledge of local market requirements in terms of culture, language, working practices, regulation and organizational structure.

www.isofthealth.com

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...